ZIC1 is downregulated through promoter hypermethylation in gastric cancer

Biochemical and Biophysical Research Communications
Liang Jing WangJoseph J Y Sung

Abstract

As one of major epigenetic changes responsible for tumor suppressor gene inactivation in the development of cancer, promoter hypermethylation was proposed as a marker to define novel tumor suppressor genes. In the current study we identified ZIC1 (Zic family member 1, odd-paired Drosophila homolog) as a novel tumor suppressor gene silenced through promoter hypermethylation in gastric cancer, the second leading cause of cancer death worldwide. In all of gastric cancer cells lines examined, ZIC1 expression was downregulated and such downregulation was accompanied with the hypermethylation of ZIC1 promoter. Demethylation treatment with 5-aza-2'-deoxycytidine (Aza) reversed ZIC1 downregulation, highlighting the importance of promoter methylation to ZIC1 downregulation in gastric cancer cells. Notably, ZIC1 expression was significantly downregulated in primary gastric carcinoma tissues in comparison with non-tumor adjacent gastric tissues (p<0.01). Accordingly, promoter methylation of ZIC1 was frequently detected in primary gastric carcinoma tissues (94.6%, 35/37) but not normal gastric tissues, indicating that promoter hypermethylation mediated ZIC1 downregulation may play an important role in gastric carcinogenesis. Indeed, ectopi...Continue Reading

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 10, 2001·The Journal of Biological Chemistry·Y KoyabuK Mikoshiba
May 18, 2001·Nature·B A Ponder
Jul 13, 2002·The Journal of Pathology·Mairi Brittan, Nicholas A Wright
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Ka-Fai ToJoseph J Y Sung
Mar 5, 2004·Cancer Cell·Toshikazu Ushijima, Mitsuru Sasako
Dec 5, 2006·International Journal of Oncology·Masuko Katoh, Masaru Katoh
Dec 21, 2006·Current Opinion in Genetics & Development·Monideepa RoyJon C Aster
Jan 24, 2007·Journal of Cellular Physiology·Paraskevi VogiatziAntonio Giordano
Mar 31, 2007·Journal of Biochemistry and Molecular Biology·Toshikazu Ushijima
Sep 12, 2007·Trends in Cell Biology·Ariel Ruiz i AltabaBarbara Stecca
Mar 14, 2008·The New England Journal of Medicine·Manel Esteller
Jul 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jun YuJoseph J Y Sung
Nov 6, 2008·British Journal of Cancer·Y Y ChengF K L Chan

❮ Previous
Next ❯

Citations

Apr 28, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jie PanLiang Jing Wang
Oct 21, 2009·Journal of Biomedical Science·Xian WangYun Wah Lam
Nov 9, 2011·Chinese Journal of Cancer·Xiao-Tong Hu, Chao He
May 2, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yan-Ying WangZeng-Guang Xu
Dec 5, 2014·BMC Medicine·Brittany N LasseigneRichard M Myers
Mar 26, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Rejane Hughes CarvalhoSjaak Philipsen
Jan 25, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yuen Yee ChengGlen Reid
Dec 17, 2015·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Xing GuHou-Zhong Ding
May 15, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yiping QuPeng Hou
Jun 19, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Rui-Lan HuangKenneth P Nephew
Sep 29, 2018·CNS Neuroscience & Therapeutics·Ji-Qiang FuChen Zhang
Sep 19, 2014·World Journal of Gastroenterology : WJG·Jun NakamuraKohji Miyazaki
Feb 18, 2020·International Journal of Cancer. Journal International Du Cancer·Zhi-Hua LiuQian Zhong
Apr 2, 2014·The Journal of Clinical Endocrinology and Metabolism·Wei QiangPeng Hou
May 14, 2016·International Journal of Molecular Medicine·Gang MaQianjun Li
Jan 8, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Qiwei GeLiangjing Wang
Jun 21, 2013·Expert Review of Molecular Diagnostics·Koji OtaniJun Yu
Jan 26, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wina VerlaatRenske D M Steenbergen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.